Related Experiment Video
Updated: Jun 16, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Single-cell transcriptomics reveals tumor landscape in ovarian carcinosarcoma
Junfen Xu1,2, Mengyan Tu3
1Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China. xjfzu@zju.edu.cn.
This study used single-cell RNA sequencing to analyze ovarian carcinosarcoma (OCS), revealing distinct epithelial and mesenchymal cell populations. Findings highlight specific molecular pathways and cell subtypes, offering insights into OCS diversity.
Area of Science:
- Oncology
- Genomics
- Cell Biology
Background:
- Ovarian carcinosarcoma (OCS) is a rare and aggressive malignancy.
- Understanding the cellular and molecular heterogeneity of OCS is crucial for developing targeted therapies.
Purpose of the Study:
- To characterize the cellular composition of ovarian carcinosarcoma (OCS) using single-cell RNA sequencing (scRNA-seq).
- To identify the molecular characteristics and interactions between epithelial and mesenchymal components within OCS.
- To compare OCS molecular profiles with high-grade serous ovarian carcinoma (HGSOC).
Main Methods:
- Single-cell RNA sequencing (scRNA-seq) was performed on resected primary OCS.
- Immunohistochemistry was utilized for validation purposes.
- scRNA-seq data were compared with existing data from HGSOC and other OCS tumors.
Main Results:
- Identified four epithelial cell subclusters with distinct biological roles, including one associated with drug resistance (high BRCA1 and TOP2A expression).
- Revealed fibroblast growth factor (FGF) and pleiotrophin (PTN) signaling as key communication pathways between epithelial and mesenchymal cells.
- Discovered a unique mesenchymal subcluster (C14) in OCS with specific gene expression patterns (e.g., CYP24A1, COL23A1, CCK, BMP7, PTN, WIF1, IGF2), distinct from HGSOC and normal ovarian tissue.
Conclusions:
- This study provides the first single-cell transcriptomics signature of human OCS.
- The identified molecular characteristics and cellular diversity offer a valuable resource for future research and therapeutic strategies in OCS.
More Related Videos
07:59Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Tumor Microenvironment